Journals / Diagnostic and Interventional Radiology / 2015 / Cilt: 21 - Sayı: 2

Abdominal sarcoidosis: cross-sectional imaging findings

Pages
111–117
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report we reviewed the cross-sectional imaging findings of hepatobiliary, gastrointestinal, and genitourinary sarcoidosis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sarcoidosis is a multisystem inflammatory disease of unknown etiology.
📊
Key Findings & Data:Extrapulmonary involvement is reported in 30% of patients, and the abdomen is the most common extrapulmonary site with a frequency of 50%-70%.
💡
Conclusion & Impact:In this report we reviewed the cross-sectional imaging findings of hepatobiliary, gastrointestinal, and genitourinary sarcoidosis
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Sarcoidosis is a multisystem inflammatory disease of unknown etiology. The lungs and the lymphoid system are the most commonly involved organs. Extrapulmonary involvement is reported in 30% of patients, and the abdomen is the most common extrapulmonary site with a frequency of 50%-70%. Although intra-abdominal sarcoidosis is usually asymptomatic, its presence may affect the prognosis and treatment options. The lesions are less characteristic and may mimick neoplastic or infectious diseases such as lymphoma, diffuse metastasis, and granulomatous inflammation. The liver and spleen are the most common abdominal sites of involvement. Sarcoidosis of the gastrointestinal system, pancreas, and kidneys are extremely rare. Adenopathy which is most commonly found in the porta hepatis, exudative ascites, and multiple granulomatous nodules studding the peritoneum are the reported manifestations of abdominal sarcoidosis.Since abdominal sarcoidosis is less common and long-standing, unrecognized disease can result in significant morbidity and mortality. Imaging contributes to diagnosis and management of intra-abdominal sarcoidosis. In this report we reviewed the cross-sectional imaging findings of hepatobiliary, gastrointestinal, and genitourinary sarcoidosis

🔖

Cite This Article

GEZER, N. S., AKIN, I. B., ALTAY, C., HARMAN, M., ROCHER, L., KARABULUT, N., SEÇİL, M. (2015). Abdominal sarcoidosis: cross-sectional imaging findings. Diagnostic and Interventional Radiology, Cilt: 21 - Sayı: 2, 111–117. https://ajindex.com/articles/350072

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Chesnutt MS, Gifford AH, Prendergast TJ. Pulmonary disorders. In: McPhee SJ, Papa- dakis MA, Tierney LM, eds. Current med- ical diagnosis & treatment. 49th ed. New York: McGraw-Hill, 2010.
  2. Baughman RP, Lower EE. Sarcoidosis. In: Fauci A, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, eds. Harrison's principles of internal medicine. 17th ed. New York: McGraw Hill, 2008.
  3. Rybicki BA, Major M, Popovich J Jr, Ma- liarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145:234-241. [CrossRef] MacArthur KL, Forouhar F, Wu GY. Intra-ab- dominal complications of sarcoidosis. J Formos Med Assoc 2010; 109:484-492. [CrossRef] Prabhakar HB, Rabinowitz CB, Gibbons FK, O'Donnell WJ, Shepard JA, Aquino SL. Imaging features of sarcoidosis on MDCT, FDG PET, and PET/CT. AJR Am J Roentge- nol 2008; 190:1-6. [CrossRef] Kennedy PT, Zakaria N, Modawi SB, et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroen- terol Hepatol 2006; 18:721-726. [CrossRef] Hercules HD, Bethlem NM. Value of liver biopsy in sarcoidosis. Arch Pathol Lab Med 1984; 108:831-834. Judson MA. Hepatic, splenic, and gastroin- testinal involvement with sarcoidosis. Se- min Respir Crit Care Med 2002; 23:529-541. [CrossRef] Warshauer DM, Molina PL, Hamman SM, et al. Nodular sarcoidosis of the liver and spleen: Analysis of 32 cases. Radiology 1995; 195:757-762. [CrossRef] Deutch SJ, Sandler MA, Tankanow LB. Ab- dominal lymphadenopathy in sarcoidosis. J Ultrasound Med 1987; 6:237-242.
  4. Britt AR, Francis IR, Glazer GM, Ellis JH. Sarcoidosis: abdominal manifestations at CT. Radiology 1991; 178:91-94. [CrossRef] Folz SJ, Johnson CD, Swensen SJ. Abdom- inal manifestations of sarcoidosis in CT studies. J Comput Assist Tomogr 1995; 19:573-579. [CrossRef] Moreno-Merlo F, Wanless IR, Shimam- atsu K, Sherman M, Greig P, Chiasson D. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrho- sis and portal hypertension in sarcoidosis. Hepatology 1997; 26:554-560. [CrossRef] Chalasani P, Vohra M, Sheagren JN. An as- sociation of sarcoidosis with hepatocellular carcinoma. Ann Oncol 2005; 16:1714-1715. [CrossRef] Freed JS, Reiner MA. Acute cholecystitis as a complication of sarcoidosis. Arch Intern Med 1983; 143:2188-2189. [CrossRef] Mert A, Avsar S, Ozaras R, et al. Gallbladder involvement in sarcoidosis. J Clin Gastro- enterol 2004; 38:612-613. [CrossRef] Bloom R